Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

MT newswireMT newswire2026/09/17 15:09
11:09 AM EDT, 09/17/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were rising sharply late Thursday morning, up 1.24% to 1,928.04 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biopharmaceutical companies Cellectis (CLLS) and DBV Technologies (DBVT), which advanced 10.9% and 5.2% respectively. They were followed by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which rose 4.6% and 4.1% respectively. The decliners from continental Europe were led by brewing company Anheuser-Busch InBev (BUD) and oil and gas company Eni (E), which fell 1% and 0.7% respectively. They were followed by healthcare tech company Royal Philips (PHG), which was off 0.1% respectively. The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and biotech firm Trinity Biotech (TRIB), which increased 4% and 3.1% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were up 3% and 2.9% respectively. The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software firm Endava (DAVA), which dropped 19.8% and 0.6% respectively. They were followed by medical device maker Smith & Nephew (SNN) and oil and gas company BP (BP), which lost 0.6% and 0.2% respectively.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56

Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.

After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.

智通财经•2026/11/06 07:53